Custom crystal commemorative celebrating the launch of Wynzora Cream, a topical treatment for plaque psoriasis that received approval from the FDA (Food and Drug Administration) in 2020. The product launch resulted from a collaboration agreement between Denmark-based MC2 Therapeutics, and EPI Health, a specialty pharmaceutical firm headquartered in Charleston, South Carolina.
(21ADH022)Crystal deal toy commemorating a follow-on offering by electroCore, a bioelectronic medicine company.
(21AJH117)Crystal deal toy commemorating a private placement by X4 Pharmaceuticals.
(21ALJ247)Crystal deal toy marking the sale of a royalty interest in OXLUMO. OXLUMO has been approved by both the Food and Drug Administration (FDA), and the European Medicine’s Agency (EMA).
(21ALJ215)Crystal deal toy marking a capital raise by eye care firm Visioneering Technologies.
(21ALJ208)Crystal deal toy commemorating Series A financing for Interius BioTherapeutics, a preclinical stage gene therapy firm.
(21AKL266)Lucite deal toy celebrating the acquisition of DivvyDose, The Illinois-based online pharmacy delivers pills in pre-sorted packs.
(21AKL199)
